Comparison of the Decannulation Protocol With Suctioning and Capping in Severe Acquired Brain Injury Patients

Sponsor
Fu Xing Hospital, Capital Medical University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04835272
Collaborator
(none)
104
1
2
23.9
4.3

Study Details

Study Description

Brief Summary

Single-center randomized trail focused on tracheostomized patients with severe acquired brain injury , comparing two different decannulation protocols:

  1. an assessment of readiness for decannulation that was based on suctioning frequency

  2. an assessment that was based on tracheostomy capping

Condition or Disease Intervention/Treatment Phase
  • Procedure: the Decannulation Protocol With Suctioning
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
104 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Tracheostomy Decannulation in Severe Acquired Brain Injury: a Decannulation Protocol With Suctioning or Capping?
Anticipated Study Start Date :
Nov 1, 2021
Anticipated Primary Completion Date :
Mar 30, 2023
Anticipated Study Completion Date :
Oct 30, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: control group

In the control group, the decision to decannulate was based on a 48-hour capping trial.

Experimental: intervention group

In the intervention group, the decision to decannulate was based on suctioning frequency.

Procedure: the Decannulation Protocol With Suctioning
In the intervention group, the decision to decannulate was based on suctioning frequency. Patients underwent decannulation when they had had no more than two aspirations every 8 hours during during a 24-hour period. Patients in this group did not undergo capping trials.
Other Names:
  • the Decannulation Protocol With Capping
  • Outcome Measures

    Primary Outcome Measures

    1. the time to decannulation [From the date of randomization to decannulation, and the patients will be followed for the duration of hospital stay, an expected average of 3 months]

      the time from randomization to actual decannulation

    Secondary Outcome Measures

    1. Rate of decannulation failure [within 1 week after decannulation]

      reintubation within 1 week after decannulation

    2. high dependency unit length of stay [From the date of high dependency unit admission to transferring to rehabilitation ward, and the patients will be followed for the duration of high dependency unit stay, an expected average of 2 months]

      the time from high dependency unit admission to rehabilitation ward

    3. Rate of respiratory infections [From the date of high dependency unit admission to hospital discharge, and the patients will be followed for the duration of hospital stay, an expected average of 3 months]

      post decannulation respiratory infections rate in each study group

    4. Glasgow Outcome Scale(GOS) six months after the acute brain injury [follow-up six months after discharge]

      The GOS is a brief descriptive outcome scale(from 0 point to 29 points, higher score means worse outcome). GOS six months after discharge to asess the prognosis of the patient

    5. Functional Independence Measure(FIM) six months after the acute brain injury [follow up six months after discharge]

      The FIM is an 18-item ordinal scale, is viewed as most useful for assessment of progress during inpatient rehabilitation(from 18 points to 126 points, higher score means better outcome).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Within three months of onset

    • Age≥18 years old

    • GCS≥8

    • Clinical stability( defined as the absence of fever, sepsis, or active infection and hemodynamic stability)

    • Without massive pooling or silent aspiration of saliva, more than one efficient swallow per minute, adequate cough reflex were tested by gently touching the aryepiglottic region with the tip of the endoscope.

    • Passing a tracheostomy-tube de-cuff test(de-cuff the tube for 3 days without pulmonary complications.

    • Without significant airway stenosis.

    Exclusion Criteria:
    • Patients with pending diagnostic or therapeutic procedures and were considered by the clinicians to be at risk for neurologic deterioration

    • Medical history of severe respiratory system or heart disease

    • Neuromuscular disease other than ICU-acquired weakness, or tracheostomy for airway control

    • Don't get informed consent from patient or guardian

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fuxing hospital, capital medical university Beijing China

    Sponsors and Collaborators

    • Fu Xing Hospital, Capital Medical University

    Investigators

    • Study Chair: Yong Wang, Rehabilitation medicine center, Fuxing hospital, capital medical university

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Song Lu, Attending doctor, Fu Xing Hospital, Capital Medical University
    ClinicalTrials.gov Identifier:
    NCT04835272
    Other Study ID Numbers:
    • songlu20210320
    First Posted:
    Apr 8, 2021
    Last Update Posted:
    Oct 18, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Song Lu, Attending doctor, Fu Xing Hospital, Capital Medical University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 18, 2021